At the end of October, a jury in St. Louis, Missouri, awarded $67.5 million to a plaintiff who stated her ovarian cancer was the result of using Johnson & Johnson Baby Powder – a product containing talc. This is the third loss in a row for the pharmaceutical and health care products company. All three trials were held in a state court in St. Louis. So far, J&J’s total liability amounts to approximately $195 million. Although such awards are often reduced and sometimes even overturned on appeal, the prospects aren't looking good for the defendants.
Talcum powder, a seemingly innocuous, everyday household product for well over a century, has turned deadly for some users. Specifically, for the women who have found themselves victim of ovarian cancer as a result of using talcum powder in the genital region. What manufacturers have known (or should have known) for at least 45 years is that the substance can cause chronic inflammation – a condition that medical science has connected with the development of some types of cancer.
Talcum powder, a seemingly innocuous substance, has been used by women for various personal and household purposes for well over a century. Suddenly, it is now a cause of action by hundreds of plaintiffs who allege a connection between the use of talcum powder and cancer. Why?